Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-7-8
pubmed:abstractText
Aprotinin was used frequently in children undergoing congenital heart operations with the aim of reducing bleeding, until it was taken off the market after adult studies reported increased renal failure and death. We evaluated the safety of aprotinin in a large multicenter cohort of children undergoing congenital heart operations.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1552-6259
pubmed:author
pubmed:copyrightInfo
Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14-21
pubmed:dateRevised
2011-4-1
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Safety of aprotinin in congenital heart operations: results from a large multicenter database.
pubmed:affiliation
Division of Pediatric Cardiology, Duke University Medical Center, Durham, North Carolina 27715, USA. sara.pasquali@duke.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural